What should be documented when a physician tells an elderly patient to stop long-term digoxin?

The short version: when a digoxin stop is not documented through to the pharmacy, the patient is at risk of digoxin toxicity from a refill that should never have been filled.

The question is about what should be documented when a physician tells an elderly patient to stop long-term digoxin. The answer has to be specific enough to prevent the failure the previous answer described: a stopped prescription that stays active in the pharmacy system.

The evidence on medication errors is directly on point. One large review found that 85% of admission medication errors originated from poor medication histories [1]. Errors in the 36-facility study occurred in 14.6% of medication doses [1]. Those are the background rates. When a digoxin stop is not documented, it becomes another error waiting to happen.

The elderly body matters for pharmacokinetics. In elderly patients, digoxin half-life is roughly double what it is in younger adults: 69.6 hours oral, 68.8 hours IV, compared to 36.8 and 38.2 hours in younger patients [2]. Total-body clearance drops by more than half: 0.8 mL/min/kg in the elderly versus 1.7 in younger adults [2]. That means a digoxin dose that was safe at age 60 can accumulate to toxic levels by age 80 on the same prescription, and a stopped order that is accidentally refilled carries even more risk because clearance is slower and the drug stays in the body longer.

What should be documented specifically. The physician should write the stop order in the medical record with the date, time, and the clinical reason (for example: "digoxin discontinued, atrial fibrillation rate controlled on beta blocker" or "digoxin discontinued, no longer indicated for heart failure with preserved ejection fraction" or "digoxin discontinued due to rising creatinine and concern for toxicity"). The discharge summary or visit note should include that the treating provider communicated the stop to the patient and caregiver verbally. The pharmacist who will process the next refill needs to receive a direct cancellation order, not just a note in a chart they do not see. The medication list at every subsequent visit should be updated on the spot, not deferred.

The evidence does not require a digoxin-specific study to make this call. The pattern is the same for every narrow-therapeutic-index drug. The pharmacist-led intervention studies show that discontinuation of inappropriate medications was the single most common pharmacist intervention in one study: 60 of 111 total interventions [1]. That is the practical measure of how often a stop order that was ordered never made it through the system.

My call: document the stop with date, time, clinical reason, patient and caregiver notification, and a direct cancellation sent to the pharmacy. Without those four elements, the patient is on their own to remember not to refill a prescription that will keep arriving in the mail. Confidence: high.